1. A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond. (2nd May 2022) Authors: Noel, Marcus S.; Kim, Semmie; Hartley, Marion L.; Wong, Steve; Picozzi, Vincent J.; Staszewski, Harry; Kim, Dae Won; Van Tornout, Jan M.; Philip, Philip Agop; Chung, Vincent; Ocean, Allyson J.; Wang‐Gillam, Andrea Journal: Cancer medicine Issue: Volume 11:Number 22(2022) Page Start: 4169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gastric carcinoma's primary presentation as multiple cutaneous nodules throughout the body. (2022) Authors: Bajoghli, Amir A; Piselli, Alexandra; Kemprecos, Helen; Khosravi, Hamed; Cardis, Michael A.; Noel, Marcus S. Journal: Cancer treatment and research communications Issue: Number 31(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial. (April 2023) Authors: Bekaii-Saab, Tanios; Okusaka, Takuji; Goldstein, David; Oh, Do-Youn; Ueno, Makoto; Ioka, Tatsuya; Fang, Weijia; Anderson, Eric C.; Noel, Marcus S.; Reni, Michele; Choi, Hye Jin; Goldberg, Jonathan S.; Oh, Sang Cheul; Li, Chung-Pin; Tabernero, Josep; Li, Jian; Foos, Emma; Oh, Cindy; Van Cutsem, Eric Journal: EClinicalMedicine Issue: Volume 58(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗